Vericel Corp. (VCEL)
37.98
+0.68
(+1.82%)
USD |
NASDAQ |
Dec 09, 11:54
Vericel Market Cap: 1.921B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.717B |
| Vanda Pharmaceuticals, Inc. | 370.54M |
| ACADIA Pharmaceuticals, Inc. | 4.647B |
| Veracyte, Inc. | 3.441B |
| Aldeyra Therapeutics, Inc. | 295.40M |
Market Cap Related Metrics
| PE Ratio | 157.72 |
| PS Ratio | 7.501 |
| PEG Ratio | 0.5517 |
| Price to Book Value | 5.968 |
| Price to Free Cash Flow | 95.24 |
| Price | 37.98 |
| Earnings Yield | 0.63% |
| PEGY Ratio | 0.5517 |
| Operating PE Ratio | 273.03 |
| Normalized PE Ratio | 157.66 |